Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leonard R. Friedland
Potential Benefits of Using a Multicomponent Vaccine for Prevention of Serogroup B Meningococcal Disease
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Safety and Immunogenicity of a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine When Co-Administered With Influenza Vaccine in Adults
Human Vaccines
Related publications
Adoption of Serogroup B Meningococcal Vaccine Recommendations
Pediatrics
Child Health
Pediatrics
Perinatology
The New Multicomponent Vaccine Against Meningococcal Serogroup B, 4CMenB: Immunological, Functional and Structural Characterization of the Antigens
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Impact of Serogroup a Meningococcal Conjugate Vaccine for Africa
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Epidemiology and Prevention of Bacterial Meningitis and Meningococcal Serogroup B Infection
Cocuk Enfeksiyon Dergisi
Child Health
Infectious Diseases
Pediatrics
Perinatology
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications?
Pediatrics
Child Health
Pediatrics
Perinatology
Vaccinating Italian Infants With a New Multicomponent Vaccine (Bexsero®) Against Meningococcal B Disease: A Cost-Effectiveness Analysis
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Epidemiology of Serogroup B Invasive Meningococcal Disease in Ontario, Canada, 2000 to 2010
BMC Infectious Diseases
Infectious Diseases
Predicted Strain Coverage of a Meningococcal Multicomponent Vaccine (4CMenB) in Portugal
PLoS ONE
Multidisciplinary
Clonal Spread of Serogroup W135 Meningococcal Disease in Turkey
Journal of Clinical Microbiology
Microbiology
